Supplier profile
GlaxoSmithKline d.o.o.
Every public-sector award we hold for this supplier, across Croatia, from 25 Mar 2015 to 4 Apr 2021.
Awards won
37
all time
Attributed value
€2.7m + HRK 229.3m
7 shared, unvalued
Buyers
2
public bodies
Active
2015–2021
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO | 23 | HRK 140.3m |
| Hrvatski zavod za javno zdravstvo | 14 | €2.7m + HRK 88.9m |
What they win
Awards
Showing 26–37 of 37 awards we hold
- Croatia-Zagreb: Vaccines ↗Hrvatski zavod za javno zdravstvoHRK 3.8mawarded 26 Dec 2018
- Cjepivo protiv hepatitisa A, inaktivirano, adsorbirano, formulacija za odrasle za 2018. godinu ↗HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVOHRK 108kawarded 30 Oct 2018
- Croatia-Zagreb: Vaccines ↗Hrvatski zavod za javno zdravstvoHRK 18.1mawarded 25 Feb 2017
- Nabava cjepiva protiv difterije; tetanusa; pertusisqa (nestanično; komponentno); heptitisa B; poliomijelitisa (inaktivirano) i hemofilusa tipa B (konjugirano); adsorbirano; nabava za djecu stariju od 24 mjeseca za 2016. godinu ↗Hrvatski zavod za javno zdravstvoshared awardawarded 29 Jun 2016
- Nabava cjepiva protiv difterije; tetanusa i pertusisa (nestanično; komponentno); adosrbirano za 2016. godinu ↗Hrvatski zavod za javno zdravstvoshared awardawarded 29 Dec 2015
- Nabava Cjepiva protiv Hepatitisa B (rDNK) (za djecu); za 2016.–2018. godinu ↗Hrvatski zavod za javno zdravstvo€1.5mawarded 23 Dec 2015
- Nabava dvomjesečne zalihe cjepiva protiv morbila; parotitisa i rubele; živo za 2015. godinu ↗Hrvatski zavod za javno zdravstvoshared awardawarded 17 Dec 2015
- Cjepivo protiv humanog papilomavirusa za 2015.godinu ↗Hrvatski zavod za javno zdravstvoshared awardawarded 22 Oct 2015
- Nabava cjepiva protiv morbila; parotitisa i rubele; živo; za 2016.–2018. godinu ↗Hrvatski zavod za javno zdravstvo€1.2mawarded 16 Oct 2015
- Cjepivo protiv difterije; tetanusa; pertusisa (nestanično; komponentno); hepatitisa B; poliomijelitisa (inaktivirano) i hemofilusa tipa B (konjugirano); adsorbirano za 2015. godinu ↗Hrvatski zavod za javno zdravstvoshared awardawarded 19 Jun 2015
- Cjepivo protiv pneumokoka; polisaharidno; konjugirano; adsorbirano; nabava za djecu do 5 godina starosti; za 2015. godinu ↗Hrvatski zavod za javno zdravstvoshared awardawarded 20 Apr 2015
- Cjepivo protiv morbila; parotitisa i rubele; živo ↗Hrvatski zavod za javno zdravstvoshared awardawarded 25 Mar 2015
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.